Rapamycin + Quercetin Interaction

⚠️ RESEARCH-BASED INTERACTION DATA — NOT COMPREHENSIVE.

Interaction Type: synergistic | Evidence Level: theoretical

Rapamycin (mTOR inhibitor) and quercetin (senolytic) target two distinct hallmarks of aging — mTOR hyperactivation and senescent cell accumulation — potentially providing complementary anti-aging effects.

Mechanism of Interaction

Rapamycin inhibits mTORC1, promoting autophagy and reducing SASP secretion from senescent cells. Quercetin (as part of D+Q) directly kills senescent cells by inhibiting their anti-apoptotic survival pathways. Rapamycin may actually reduce the NEED for senolytics by suppressing SASP, while quercetin clears cells that rapamycin cannot eliminate.

Clinical Relevance

No clinical trials of this specific combination. Theoretical rationale is strong — targeting two independent aging mechanisms. Timing matters: rapamycin weekly, D+Q monthly. Some longevity clinicians are combining these in clinical practice.

Recommendations

• Stagger timing — weekly rapamycin + monthly D+Q cycles
• Monitor immune function (both affect immunity through different mechanisms)
• Rapamycin's SASP suppression may complement quercetin's cell killing
• Consult with a longevity-focused physician before combining

Relevant Conditions

• Longevity / healthspan
• Age-related disease prevention